@article{Sachin C. Joshi_Amit V. Kakad_Vardhaman A. Murkunde_Gayatri N. Kanade_2022, title={Viral Infection- A Looming Catastrophe: https://doi.org/10.54037/WJPS.2022.100405}, volume={10}, url={https://wjpsonline.com/index.php/wjps/article/view/viral-infection-looming-catastrophe}, abstractNote={<p>The common cold, influenza, chickenpox, human immunodeficiency virus (HIV), SARS-CoV-2, and other disease-causing (pathogenic) viruses crop up when most people hear the word "virus." Infectious diseases are predicted to account for over one-third (i.e., 20 million) of annual deaths worldwide, as per the World Health Organization (WHO). The rising globalized health sector has made major contributions to the improvement of human health. However, long-standing, developing, and re-emerging infectious disease risks continue to haunt the globe. With a pandemic on the scale of COVID-19, Antibiotic resistance is a veiled concern looming behind the COVID-19 pandemic, which has already claimed thousands of lives before the global breakout. With the worrisome rise in antibiotic resistance incidences only few new antimicrobial drugs on the horizon, it’s essential to keep monitor of pathogen epidemiology in ways that will improve treatment decisions. This review article aimed to outline recent findings of the origin, transmission, diagnosis, precautionary measures, antimicrobial resistance, reinfection and repurposing of drugs for the treatment and prevention of COVID-19 depending on the previous literature.</p>}, number={04}, journal={World Journal of Pharmaceutical Sciences}, author={Sachin C. Joshi and Amit V. Kakad and Vardhaman A. Murkunde and Gayatri N. Kanade}, year={2022}, month={Apr.}, pages={38–43} }